Drug profile · INN
dinoprost tromethamine
PROSTIN F2 ALPHA
dinoprost tromethamine (PROSTIN F2 ALPHA) is a prostanoid fp receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — dinoprost tromethamine
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
dinoprost tromethamine (PROSTIN F2 ALPHA) is a prostanoid fp receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Prostanoid FP receptor agonist
Primary target: Prostaglandin F2-alpha receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is dinoprost tromethamine?
dinoprost tromethamine (PROSTIN F2 ALPHA) is a prostanoid fp receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for dinoprost tromethamine?
PROSTIN F2 ALPHA is a marketed brand name for dinoprost tromethamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dinoprost tromethamine?
dinoprost tromethamine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.